High concentration formulation developability approaches and considerations
ABSTRACTThe growing need for biologics to be administered subcutaneously and ocularly, coupled with certain indications requiring high doses, has resulted in an increase in drug substance (DS) and drug product (DP) protein concentrations. With this increase, more emphasis must be placed on identifyi...
Main Authors: | Jonathan Zarzar, Tarik Khan, Maniraj Bhagawati, Benjamin Weiche, Jasmin Sydow-Andersen, Alavattam Sreedhara |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2211185 |
Similar Items
-
Computational models for studying physical instabilities in high concentration biotherapeutic formulations
by: Marco A. Blanco
Published: (2022-12-01) -
Formulation of Multifunctional Material Dispersions
by: Tamas Szabo, et al.
Published: (2014-06-01) -
Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection
by: Jason Wallach, et al.
Published: (2022-03-01) -
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
by: M. Desai, et al.
Published: (2023-12-01) -
A Comparative Evaluation of Desoximetasone Cream and Ointment Formulations Using Experiments and In Silico Modeling
by: Namrata S. Matharoo, et al.
Published: (2023-10-01)